Collaborative normal tension glaucoma study
- PMID: 12698048
- DOI: 10.1097/00055735-200304000-00006
Collaborative normal tension glaucoma study
Abstract
Purpose of review: Before this study was done, there was a difference of opinion concerning whether intraocular pressure (IOP) was involved in producing optic nerve damage when there was glaucomatous damage to the optic nerve and characteristic visual field loss, even though the IOP was in the statistically normal range. This article reviews the findings of a collaborative study aimed at finding the answer to this question.
Recent findings: The level of pressure influences the course of normal tension glaucoma, as evidenced by a slower rate of incident visual field loss in cases with 30% or more lowering of intraocular pressure. The rate of progression without treatment is highly variable, but often slow enough that half of the patients have no progression in 5 years. A faster rate occurs in women, in patients with migraine headaches, and in the presence of disc hemorrhages. Some patients may experience greater benefit from lowering of IOP than others, but further research is needed to be able to identify those most likely to benefit.
Summary: As a group, patients with normal tension glaucoma benefit from lowering of IOP. Variable rate of deterioration, as well as lack of progression in a substantial number in 5 years, suggest that treatment should be individualized according to the stage of disease and rate of progression. Traits that help predict risk and rate of progression and response to treatment are beginning to become known and, when fully known, will help guide management decisions.
Similar articles
-
[Clinical approach to normal intraocular pressure glaucoma].Acta Med Croatica. 2005;59(2):123-8. Acta Med Croatica. 2005. PMID: 15909886 Review. Croatian.
-
Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Collaborative Normal-Tension Glaucoma Study Group.Am J Ophthalmol. 1998 Oct;126(4):487-97. doi: 10.1016/s0002-9394(98)00223-2. Am J Ophthalmol. 1998. PMID: 9780093 Clinical Trial.
-
[Aiming for zero blindness].Nippon Ganka Gakkai Zasshi. 2015 Mar;119(3):168-93; discussion 194. Nippon Ganka Gakkai Zasshi. 2015. PMID: 25854109 Review. Japanese.
-
Risk factors for visual field progression in treated glaucoma.Arch Ophthalmol. 2011 May;129(5):562-8. doi: 10.1001/archophthalmol.2011.72. Arch Ophthalmol. 2011. PMID: 21555607
-
Factors that predict the benefit of lowering intraocular pressure in normal tension glaucoma.Am J Ophthalmol. 2003 Nov;136(5):820-9. doi: 10.1016/s0002-9394(03)00478-1. Am J Ophthalmol. 2003. PMID: 14597032 Clinical Trial.
Cited by
-
Neuroprotection, Growth Factors and BDNF-TrkB Signalling in Retinal Degeneration.Int J Mol Sci. 2016 Sep 20;17(9):1584. doi: 10.3390/ijms17091584. Int J Mol Sci. 2016. PMID: 27657046 Free PMC article. Review.
-
Study on Incentives for Glaucoma Medication Adherence (SIGMA): study protocol for a randomized controlled trial to increase glaucoma medication adherence using value pricing.Trials. 2016 Jul 15;17(1):316. doi: 10.1186/s13063-016-1459-1. Trials. 2016. PMID: 27422389 Free PMC article.
-
Relationship between Alcohol Consumption and Ocular Pressure according to Facial Flushing in Korean Men with Obesity.Korean J Fam Med. 2019 Nov;40(6):399-405. doi: 10.4082/kjfm.18.0131. Epub 2019 Oct 31. Korean J Fam Med. 2019. PMID: 31668053 Free PMC article.
-
Optic Disc Hemorrhage Is Not Associated with Global Choroidal Vessel Loss, but Is Associated with Localized Choroidal Vessel Loss in Glaucoma.J Clin Med. 2022 Feb 18;11(4):1080. doi: 10.3390/jcm11041080. J Clin Med. 2022. PMID: 35207349 Free PMC article.
-
New glaucoma medications: latanoprostene bunod, netarsudil, and fixed combination netarsudil-latanoprost.Eye (Lond). 2020 Jan;34(1):72-88. doi: 10.1038/s41433-019-0671-0. Epub 2019 Nov 6. Eye (Lond). 2020. PMID: 31695162 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials